This detailed report on ‘Insomnia Market’ put offers a succinct study on regional forecast, industry size, revenue estimations related to the industry. The report further emphasizes primary challenges and growth trends adopted by leading manufacturers of the dynamic competitive spectrum of the market.
Global Insomnia Market is valued around USD 4494.51 Million in 2018 and expected to reach USD 6091.87 Million by 2025 with the CAGR of 4.44% over the forecast period.
Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/75
Increasing demand for sleep Aids and therapy’s, growing demand of OTC sleep aids and stressful life with unsatisfactory sleep, increased workloads and shift works are some factors driving the growth of the market.
Scope of the Global Insomnia Market Report:
Insomnia may be a common disorder which will make it hard to nod off, hard to remain asleep, or cause you to awaken too early and not be ready to revisit to sleep. You’ll still feel tired once you awaken. Insomnia can give harmful effect not only your energy level and mood but also your health, work performance and quality of life.
Merck & Co. Inc., Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Ltd, Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals
How much sleep is enough varies from person to person, but most adults need seven to eight hours an evening. At some point, many adults experience short-term (acute) insomnia, which lasts for days or weeks, (for example, when you can't fall asleep the night before an exam or after receiving stressful or bad news). It’s always the results of stress or a traumatic event. But some people have long-term (chronic insomnia), which is disrupted sleep that occurs at least three nights per week and lasts at least three months. Chronic insomnia disorders can have many causes. Changes within the environment, harmful sleep habits, shift work, other clinical disorders, and certain medications could lead on to a long-term pattern of unsatisfactory sleep. People with chronic insomnia may enjoy some sort of treatment to assist them revisit to healthy sleep patterns. Chronic insomnia are often co morbid, meaning it's linked to a different medical or psychiatric issue, although sometimes it's difficult to know this cause and effect relationship.
The regions covered in this Insomnia Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Insomniais sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Insomnia Market Dynamics-
Increasing numbers of insomnia patients and prevalence of OTC drugs are the main factors of this market as per consumer reports survey of 1,767 U.S. adults; nearly one-third of individuals who complained of sleep problems a minimum of once per week said that they had used an over-the-counter or prescription sleep drug within the previous year. Around 40% of individuals who take sleep aids use the drugs in potentially harmful ways—by, for instance, taking them frequently or longer than recommended, or combining them with other medications or alcohol. 80% people had sleeping problems once in a week. 31% people who had sleep problems once in a week used OTC or Rx drugs.
Global Insomnia Market Segmentation –
By Product Type analysis: Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis
By Application Type Analysis - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store
North America dominate the Insomnia Market
North America is dominating the market of insomnia as per US National Library of drugs , Insomnia is costing the typical U.S. worker 11.3 days, or USD 2,280 in lost productivity once a year and as a nation, the whole cost is 252.7 days and USD 63.2 billion. Europe is leading the market after North America Europe is that the market during which the entire annual cost of insomnia within the province of Quebec was estimated at USD 6.6 billion (Cdn$). the typical annual per-person costs was USD 5,010 for people with insomnia syndrome, USD 1,431 for people presenting with symptoms, and USD 421 permanently sleepers. thanks to its rising population Asia Pacific is growing marketplace for Insomnia Market and also lower hospital treatment cost compare to other regions.
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org